Simpson Thacher is representing KKR in connection with its acquisition of Healthium Medtech Ltd., a leading Indian medical devices company, from an affiliate of Funds advised by Apax Partners LLP.
Founded in India in 1992, Healthium is a medical devices company that develops, manufactures and sells a broad range of surgical products globally, with a presence in more than 90 countries. Its comprehensive, high-quality portfolio caters to a wide spectrum of surgeons’ needs, offering wound closure, arthroscopy, and advanced wound closure products.
KKR is making this investment from its Asian Fund IV. The transaction is subject to receipt of certain regulatory approvals and is expected to close in the third quarter of 2024.
The Simpson Thacher team includes Ian Ho, Clare Gaskell, Jonathan Stradling, Valerie Fung, Jasper Ma, Shirley Foo and Fran Towers (M&A); Makiko Harunari, Alvin Kwong, Paul Kim and Tianyu Ma (Credit); Étienne Renaudeau, Henry Llwellyn, Lina Kim, Pauline Patat and Jessie Li (Antitrust); Meredith Jones and Ruoxi Zhang (Tax); Vanessa Burrows and Jacob Madden (Healthcare); Lori Lesser, Nicholas Westbrook, Margerite Blase, Camilla Gelson-Thomas and Alysha Sekhon (IP/data privacy); and Steven DeLott (Insurance).